ALDOA and neoplasm: High ALDOA expression in LUSC is associated with enhanced oncogenic signaling and glycolytic activity, while contributing to an immunosuppressive tumor microenvironment characterized by reduced CD8+ T-cell infiltration, increased M0 macrophage presence, and diminished immune checkpoint gene expression.